Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immune disorders and susceptibility to neoplasms.

Literature DB >> 22822327

Immune disorders and susceptibility to neoplasms.

Om Prakash¹, Javed Gill, Gist Farr.

Abstract

Entities: Disease

Year: 2002 PMID： 22822327 PMCID： PMC3399255

Source DB: PubMed Journal: Ochsner J ISSN： 1524-5012

× No keyword cloud information.

29 in total

1. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

Authors: O Prakash; Z Y Tang; Y E He; M S Ali; R Coleman; J Gill; G Farr; F Samaniego
Journal: J Natl Cancer Inst Date: 2000-05-03 Impact factor: 13.506

2. Cancers complicating organ transplantation.

Authors: I Penn
Journal: N Engl J Med Date: 1990-12-20 Impact factor: 91.245

3. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

Authors: L J Swinnen; M R Costanzo-Nordin; S G Fisher; E J O'Sullivan; M R Johnson; A L Heroux; G J Dizikes; R Pifarre; R I Fisher
Journal: N Engl J Med Date: 1990-12-20 Impact factor: 91.245

4. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.

Authors: C B Foster; T Lehrnbecher; S Samuels; S Stein; F Mol; J A Metcalf; K Wyvill; S M Steinberg; J Kovacs; A Blauvelt; R Yarchoan; S J Chanock
Journal: Blood Date: 2000-10-01 Impact factor: 22.113

Review 5. Adoptive immunotherapy following allogeneic bone marrow transplantation.

Authors: F Dazzi; J M Goldman
Journal: Annu Rev Med Date: 1998 Impact factor: 13.739

6. Cyclosporine induces cancer progression by a cell-autonomous mechanism.

Authors: M Hojo; T Morimoto; M Maluccio; T Asano; K Morimoto; M Lagman; T Shimbo; M Suthanthiran
Journal: Nature Date: 1999-02-11 Impact factor: 49.962

7. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

Authors: S A Riddler; M C Breinig; J L McKnight
Journal: Blood Date: 1994-08-01 Impact factor: 22.113

8. Primary immunodeficiencies: genetic risk factors for lymphoma.

Authors: A H Filipovich; A Mathur; D Kamat; R S Shapiro
Journal: Cancer Res Date: 1992-10-01 Impact factor: 12.701

9. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.

Authors: E Cesarman; A Chadburn; Y F Liu; A Migliazza; R Dalla-Favera; D M Knowles
Journal: Blood Date: 1998-10-01 Impact factor: 22.113

Immune disorders and susceptibility to neoplasms.

1. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

2. Cancers complicating organ transplantation.

3. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

4. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.

Review 5. Adoptive immunotherapy following allogeneic bone marrow transplantation.

6. Cyclosporine induces cancer progression by a cell-autonomous mechanism.

7. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

8. Primary immunodeficiencies: genetic risk factors for lymphoma.

9. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.

10. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.

1. Recent publications by ochsner authors.

2. Recent publications by ochsner authors.

Review 3. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Review 4. The endoplasmic reticulum stress response in prostate cancer.